Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

Shamarke Esse; Oras Alabas; Kayleigh Mason; Sarah Ryan; Nick J. Reynolds; Catherine Smith; Christopher Bunker; Christopher Griffiths; Adele Green; Richard B. Warren

doi:10.1093/bjd/ljae090.005

Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

Shamarke Esse, Oras Alabas, Kayleigh Mason, Sarah Ryan, Nick J. Reynolds, Catherine Smith, Christopher Bunker, Christopher Griffiths, Adele Green, Richard B. Warren

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	ljae090005
Pages (from-to)	I3-I4
Number of pages	2
Journal	British Journal of Dermatology
Volume	191
Issue number	Supplement 1
Early online date	28 Jun 2024
DOIs	https://doi.org/10.1093/bjd/ljae090.005
Publication status	Published - 1 Jul 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjd/ljae090.005

Cite this

Esse, S., Alabas, O., Mason, K., Ryan, S., Reynolds, N. J., Smith, C., Bunker, C., Griffiths, C., Green, A., & Warren, R. B. (2024). Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. British Journal of Dermatology, 191(Supplement 1), I3-I4. Article ljae090005. https://doi.org/10.1093/bjd/ljae090.005

Esse, Shamarke ; Alabas, Oras ; Mason, Kayleigh et al. / Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy : analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. In: British Journal of Dermatology. 2024 ; Vol. 191, No. Supplement 1. pp. I3-I4.

@article{319c40cadf18429fafc42032d357999a,

title = "Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group",

author = "Shamarke Esse and Oras Alabas and Kayleigh Mason and Sarah Ryan and Reynolds, {Nick J.} and Catherine Smith and Christopher Bunker and Christopher Griffiths and Adele Green and Warren, {Richard B.}",

year = "2024",

month = jul,

day = "1",

doi = "10.1093/bjd/ljae090.005",

language = "English",

volume = "191",

pages = "I3--I4",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons Ltd",

number = "Supplement 1",

}

Esse, S, Alabas, O, Mason, K, Ryan, S, Reynolds, NJ, Smith, C, Bunker, C, Griffiths, C , Green, A & Warren, RB 2024, 'Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group', British Journal of Dermatology, vol. 191, no. Supplement 1, ljae090005, pp. I3-I4. https://doi.org/10.1093/bjd/ljae090.005

Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. / Esse, Shamarke; Alabas, Oras; Mason, Kayleigh et al.
In: British Journal of Dermatology, Vol. 191, No. Supplement 1, ljae090005, 01.07.2024, p. I3-I4.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy

T2 - analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

AU - Esse, Shamarke

AU - Alabas, Oras

AU - Mason, Kayleigh

AU - Ryan, Sarah

AU - Reynolds, Nick J.

AU - Smith, Catherine

AU - Bunker, Christopher

AU - Griffiths, Christopher

AU - Green, Adele

AU - Warren, Richard B.

PY - 2024/7/1

Y1 - 2024/7/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001261806400088&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1093/bjd/ljae090.005

DO - 10.1093/bjd/ljae090.005

M3 - Meeting Abstract

SN - 0007-0963

VL - 191

SP - I3-I4

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - Supplement 1

M1 - ljae090005

ER -

Esse S, Alabas O, Mason K, Ryan S, Reynolds NJ, Smith C et al. Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. British Journal of Dermatology. 2024 Jul 1;191(Supplement 1):I3-I4. ljae090005. Epub 2024 Jun 28. doi: 10.1093/bjd/ljae090.005

Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

UN SDGs

Access to Document

Other files and links

Cite this